StockData

Acadia Pharmaceuticals vs Insmed

ACAD and INSM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ACAD and INSM compare

Insmed is the larger company, worth 8.5 times as much as Acadia Pharmaceuticals ($26.7B against $3.2B).

Insmed grew revenue faster over the last twelve months (240% versus 11.8% for Acadia Pharmaceuticals).

Acadia Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of 33.4% compared with −39.9% at Insmed.

Acadia Pharmaceuticals scores higher on the StockData Score (16 against 8 for Insmed), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricACADINSM
Size and price
Market cap$3.2B$26.7B
Share price$18.32$121.86
Change, 1 year−23.7%−36.9%
Change, 5 years−2.5%321%
Beta (5Y)0.530.84
Employees7981,664
StockData Score
Total score16 (better)8
Valuation score4 (better)0
Growth score23 (better)
Performance score4 (better)2
Health score6 (better)3
Dividend score00
Valuation
P/E8.3×–
P/S2.8× (better)17.6×
P/B2.4× (better)36.8×
EV/EBITDA25.5×–
P/FCF21.7×–
FCF yield4.6% (better)−2.3%
Fair value$25.26$61.10
Margin of safety27.5% (better)−99.5%
Growth
Revenue growth (TTM)11.8%240% (better)
Revenue growth, 5Y average19.4%29.8% (better)
Net income growth (TTM)71.3%–
EPS growth (TTM)66.2%–
Profitability
Gross margin91.1% (better)84.4%
Operating margin7.6% (better)−37.1%
Net margin33.4% (better)−39.9%
FCF margin12.8% (better)−41.3%
Return on equity35.7% (better)−72.5%
Return on invested capital42.1%–
Financial health
Debt / equity0.000.76 (better)
Interest coverage–−6.9×
Current ratio3.39 (better)2.86
Altman Z-score4.327.42 (better)
Piotroski F-score6 (better)4
Dividends and buybacks
Buyback yield−1.5%–
Shareholder yield−1.5%0.00% (better)
Ownership
Held by institutions97.9%102%
Held by insiders27.8%0.89%
Insider net buying, 12 months−$2.5M (better)−$133M
Superinvestors holding–1
Short interest, % of float6.7%6.5%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.